Report cover image

Global Pharma Excipients Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 193 Pages
SKU # APRC20556181

Description

Summary

According to APO Research, the global Pharma Excipients market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Pharma Excipients is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Pharma Excipients is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Pharma Excipients market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Pharma Excipients is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Pharma Excipients market include J.M. Huber Corporation, Evonik, Eastman Chemical Company, DOW Chemical Company, Cargill, BASF, Archer Daniels Midland (ADM), AkzoNobel and ABITEC Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharma Excipients, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pharma Excipients, also provides the sales of main regions and countries. Of the upcoming market potential for Pharma Excipients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharma Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharma Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharma Excipients sales, projected growth trends, production technology, application and end-user industry.

Pharma Excipients Segment by Company

J.M. Huber Corporation
Evonik
Eastman Chemical Company
DOW Chemical Company
Cargill
BASF
Archer Daniels Midland (ADM)
AkzoNobel
ABITEC Corporation
Pharma Excipients Segment by Type

Alcohols
Polymers
Minerals
Sugar
Others
Pharma Excipients Segment by Application

Oral Solid Dosage Forms (OSDF)
Others
Pharma Excipients Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Pharma Excipients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pharma Excipients market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharma Excipients significant trends, drivers, influence factors in global and regions.
6. To analyze Pharma Excipients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma Excipients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Excipients industry.
Chapter 3: Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pharma Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pharma Excipients in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pharma Excipients Sales Value (2020-2031)
1.2.2 Global Pharma Excipients Sales Volume (2020-2031)
1.2.3 Global Pharma Excipients Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Pharma Excipients Market Dynamics
2.1 Pharma Excipients Industry Trends
2.2 Pharma Excipients Industry Drivers
2.3 Pharma Excipients Industry Opportunities and Challenges
2.4 Pharma Excipients Industry Restraints
3 Pharma Excipients Market by Company
3.1 Global Pharma Excipients Company Revenue Ranking in 2024
3.2 Global Pharma Excipients Revenue by Company (2020-2025)
3.3 Global Pharma Excipients Sales Volume by Company (2020-2025)
3.4 Global Pharma Excipients Average Price by Company (2020-2025)
3.5 Global Pharma Excipients Company Ranking (2023-2025)
3.6 Global Pharma Excipients Company Manufacturing Base and Headquarters
3.7 Global Pharma Excipients Company Product Type and Application
3.8 Global Pharma Excipients Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Pharma Excipients Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Pharma Excipients Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Pharma Excipients Market by Type
4.1 Pharma Excipients Type Introduction
4.1.1 Alcohols
4.1.2 Polymers
4.1.3 Minerals
4.1.4 Sugar
4.1.5 Others
4.2 Global Pharma Excipients Sales Volume by Type
4.2.1 Global Pharma Excipients Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pharma Excipients Sales Volume by Type (2020-2031)
4.2.3 Global Pharma Excipients Sales Volume Share by Type (2020-2031)
4.3 Global Pharma Excipients Sales Value by Type
4.3.1 Global Pharma Excipients Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pharma Excipients Sales Value by Type (2020-2031)
4.3.3 Global Pharma Excipients Sales Value Share by Type (2020-2031)
5 Pharma Excipients Market by Application
5.1 Pharma Excipients Application Introduction
5.1.1 Oral Solid Dosage Forms (OSDF)
5.1.2 Others
5.2 Global Pharma Excipients Sales Volume by Application
5.2.1 Global Pharma Excipients Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pharma Excipients Sales Volume by Application (2020-2031)
5.2.3 Global Pharma Excipients Sales Volume Share by Application (2020-2031)
5.3 Global Pharma Excipients Sales Value by Application
5.3.1 Global Pharma Excipients Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pharma Excipients Sales Value by Application (2020-2031)
5.3.3 Global Pharma Excipients Sales Value Share by Application (2020-2031)
6 Pharma Excipients Regional Sales and Value Analysis
6.1 Global Pharma Excipients Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pharma Excipients Sales by Region (2020-2031)
6.2.1 Global Pharma Excipients Sales by Region: 2020-2025
6.2.2 Global Pharma Excipients Sales by Region (2026-2031)
6.3 Global Pharma Excipients Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Pharma Excipients Sales Value by Region (2020-2031)
6.4.1 Global Pharma Excipients Sales Value by Region: 2020-2025
6.4.2 Global Pharma Excipients Sales Value by Region (2026-2031)
6.5 Global Pharma Excipients Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Pharma Excipients Sales Value (2020-2031)
6.6.2 North America Pharma Excipients Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Pharma Excipients Sales Value (2020-2031)
6.7.2 Europe Pharma Excipients Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pharma Excipients Sales Value (2020-2031)
6.8.2 Asia-Pacific Pharma Excipients Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Pharma Excipients Sales Value (2020-2031)
6.9.2 South America Pharma Excipients Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pharma Excipients Sales Value (2020-2031)
6.10.2 Middle East & Africa Pharma Excipients Sales Value Share by Country, 2024 VS 2031
7 Pharma Excipients Country-level Sales and Value Analysis
7.1 Global Pharma Excipients Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Pharma Excipients Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Pharma Excipients Sales by Country (2020-2031)
7.3.1 Global Pharma Excipients Sales by Country (2020-2025)
7.3.2 Global Pharma Excipients Sales by Country (2026-2031)
7.4 Global Pharma Excipients Sales Value by Country (2020-2031)
7.4.1 Global Pharma Excipients Sales Value by Country (2020-2025)
7.4.2 Global Pharma Excipients Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Pharma Excipients Sales Value Growth Rate (2020-2031)
7.5.2 USA Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Pharma Excipients Sales Value Growth Rate (2020-2031)
7.6.2 Canada Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Pharma Excipients Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Pharma Excipients Sales Value Growth Rate (2020-2031)
7.8.2 Germany Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Pharma Excipients Sales Value Growth Rate (2020-2031)
7.9.2 France Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.9.3 France Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Pharma Excipients Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Pharma Excipients Sales Value Growth Rate (2020-2031)
7.11.2 Italy Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Pharma Excipients Sales Value Growth Rate (2020-2031)
7.12.2 Spain Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Pharma Excipients Sales Value Growth Rate (2020-2031)
7.13.2 Russia Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Pharma Excipients Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Pharma Excipients Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Pharma Excipients Sales Value Growth Rate (2020-2031)
7.16.2 China Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.16.3 China Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Pharma Excipients Sales Value Growth Rate (2020-2031)
7.17.2 Japan Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Pharma Excipients Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Pharma Excipients Sales Value Growth Rate (2020-2031)
7.19.2 India Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.19.3 India Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Pharma Excipients Sales Value Growth Rate (2020-2031)
7.20.2 Australia Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Pharma Excipients Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Pharma Excipients Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Pharma Excipients Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Pharma Excipients Sales Value Growth Rate (2020-2031)
7.24.2 Chile Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Pharma Excipients Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Pharma Excipients Sales Value Growth Rate (2020-2031)
7.26.2 Peru Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Pharma Excipients Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Pharma Excipients Sales Value Growth Rate (2020-2031)
7.28.2 Israel Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Pharma Excipients Sales Value Growth Rate (2020-2031)
7.29.2 UAE Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Pharma Excipients Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Pharma Excipients Sales Value Growth Rate (2020-2031)
7.31.2 Iran Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Pharma Excipients Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Pharma Excipients Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Pharma Excipients Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Pharma Excipients Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 J.M. Huber Corporation
8.1.1 J.M. Huber Corporation Comapny Information
8.1.2 J.M. Huber Corporation Business Overview
8.1.3 J.M. Huber Corporation Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.1.4 J.M. Huber Corporation Pharma Excipients Product Portfolio
8.1.5 J.M. Huber Corporation Recent Developments
8.2 Evonik
8.2.1 Evonik Comapny Information
8.2.2 Evonik Business Overview
8.2.3 Evonik Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.2.4 Evonik Pharma Excipients Product Portfolio
8.2.5 Evonik Recent Developments
8.3 Eastman Chemical Company
8.3.1 Eastman Chemical Company Comapny Information
8.3.2 Eastman Chemical Company Business Overview
8.3.3 Eastman Chemical Company Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.3.4 Eastman Chemical Company Pharma Excipients Product Portfolio
8.3.5 Eastman Chemical Company Recent Developments
8.4 DOW Chemical Company
8.4.1 DOW Chemical Company Comapny Information
8.4.2 DOW Chemical Company Business Overview
8.4.3 DOW Chemical Company Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.4.4 DOW Chemical Company Pharma Excipients Product Portfolio
8.4.5 DOW Chemical Company Recent Developments
8.5 Cargill
8.5.1 Cargill Comapny Information
8.5.2 Cargill Business Overview
8.5.3 Cargill Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.5.4 Cargill Pharma Excipients Product Portfolio
8.5.5 Cargill Recent Developments
8.6 BASF
8.6.1 BASF Comapny Information
8.6.2 BASF Business Overview
8.6.3 BASF Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.6.4 BASF Pharma Excipients Product Portfolio
8.6.5 BASF Recent Developments
8.7 Archer Daniels Midland (ADM)
8.7.1 Archer Daniels Midland (ADM) Comapny Information
8.7.2 Archer Daniels Midland (ADM) Business Overview
8.7.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.7.4 Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio
8.7.5 Archer Daniels Midland (ADM) Recent Developments
8.8 AkzoNobel
8.8.1 AkzoNobel Comapny Information
8.8.2 AkzoNobel Business Overview
8.8.3 AkzoNobel Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.8.4 AkzoNobel Pharma Excipients Product Portfolio
8.8.5 AkzoNobel Recent Developments
8.9 ABITEC Corporation
8.9.1 ABITEC Corporation Comapny Information
8.9.2 ABITEC Corporation Business Overview
8.9.3 ABITEC Corporation Pharma Excipients Sales, Value and Gross Margin (2020-2025)
8.9.4 ABITEC Corporation Pharma Excipients Product Portfolio
8.9.5 ABITEC Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pharma Excipients Value Chain Analysis
9.1.1 Pharma Excipients Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pharma Excipients Sales Mode & Process
9.2 Pharma Excipients Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pharma Excipients Distributors
9.2.3 Pharma Excipients Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.